Follow
Tomas Di Mambro
Tomas Di Mambro
Diatheva s.r.l
Verified email at diatheva.com
Title
Cited by
Cited by
Year
The yin and yang of current antifungal therapeutic strategies: how can we harness our natural defenses?
T Di Mambro, I Guerriero, L Aurisicchio, M Magnani, E Marra
Frontiers in pharmacology 10, 80, 2019
652019
Intracellular redox-modulated pathways as targets for effective approaches in the treatment of viral infection
A Fraternale, C Zara, M De Angelis, L Nencioni, AT Palamara, M Retini, ...
International Journal of Molecular Sciences 22 (7), 3603, 2021
382021
Humanization of antibodies using a statistical inference approach
A Clavero-Álvarez, T Di Mambro, S Perez-Gaviro, M Magnani, ...
Scientific reports 8 (1), 14820, 2018
342018
A new humanized antibody is effective against pathogenic fungi in vitro
T Di Mambro, T Vanzolini, P Bruscolini, S Perez-Gaviro, E Marra, ...
Scientific Reports 11 (1), 19500, 2021
172021
I-152, a supplier of N-acetyl-cysteine and cysteamine, inhibits immunoglobulin secretion and plasma cell maturation in LP-BM5 murine leukemia retrovirus-infected mice by …
A Fraternale, C Zara, T Di Mambro, E Manuali, DA Genovese, L Galluzzi, ...
Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1866 (12), 165922, 2020
62020
AFM evaluation of a humanized recombinant antibody affecting C. auris cell wall and stability
T Vanzolini, T Di Mambro, M Magnani, M Menotta
RSC advances 13 (9), 6130-6142, 2023
52023
Development and in vitro characterization of a humanized scFv against fungal infections
T Di Mambro, T Vanzolini, M Bianchi, R Crinelli, B Canonico, F Tasini, ...
PloS one 17 (10), e0276786, 2022
32022
Humanised antibodies against pathogenic fungi
T Di Mambro, T Vanzolini, M Magnani
US Patent App. 18/251,298, 2023
12023
CD99 Expression and Prognostic Impact in Glioblastoma: A Single-Center Cohort Study
A Rocca, F Giudici, CA Donofrio, C Bottin, M Pinamonti, B Ferrari, ...
Cells 13 (7), 597, 2024
2024
Development and characterization of DIA 12.3, a fully human intact anti-CEACAM1 monoclonal antibody
M Centonze, V Fiori, M Kujawski, L Li, P Wong, L Williams, T Di Mambro, ...
Plos one 19 (2), e0295345, 2024
2024
A biotechnological approach for the production of new protein bioplastics
F De Marchis, T Vanzolini, E Maricchiolo, M Bellucci, M Menotta, ...
Biotechnology Journal 19 (1), 2300363, 2024
2024
Sviluppo ed umanizzazione di un anticorpo in formato scFv contro β-1, 3 glucano
T DI MAMBRO
Urbino, 2015
2015
Humanization of Antibodies using a Statistical Inference Approach–Supplementary Information
A Clavero-Alvarez, T Di Mambro, S Perez-Gaviro, M Magnani, ...
The system can't perform the operation now. Try again later.
Articles 1–13